Oncology & Cancer

Blocking an enzyme may improve melanoma immunotherapy outcomes

About 65% of melanoma patients do not respond to immunotherapy. New work by the team of Prof. Max Mazzone (VIB-KU Leuven Center for Cancer Biology) discovered that an enzyme called HPGDS (expressed in a specific subset of ...

Oncology & Cancer

Targeted alpha therapy: Advances in treating refractory skin cancer

Metastatic melanoma, also known as stage IV melanoma, is a type of skin cancer that spreads to other parts of the body. It is one of the most aggressive forms of skin cancer, with current therapies—including immunotherapy ...

Oncology & Cancer

Uveal melanoma 3D models offer hope for improved treatments

Mayo Clinic researchers have developed organoid models to study uveal melanoma, one of the most common types of eye cancer in adults. Their goal is to use these models to better understand how this disease works and develop ...

page 4 from 40